Could Topical Minoxidil Cause Non-Arteritic Anterior Ischemic Optic Neuropathy?
Minoxidil hair formulation is commonly used for the treatment of male or female androgenic alopecia. Minoxidil is a Health Canada and US FDA-approved medication for hair loss in men and women. The drug is marketed as 2% and 5% topical solutions. This over-thecounter product is considered safe, but...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2016-08-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/8250/19679_CE[Ra1]_F(P)_PF1(ASAK)_PFA(AK)_PF2(PAG).pdf |
| Summary: | Minoxidil hair formulation is commonly used for the treatment of male or female androgenic alopecia. Minoxidil is a Health Canada and
US FDA-approved medication for hair loss in men and women. The drug is marketed as 2% and 5% topical solutions. This over-thecounter product is considered safe, but should be used with caution. Furthermore, minoxidil is an orally active vasodilator for treatment
of severe hypertension. Typical side effects of minoxidil are faster heart rate, augmented heart function and stroke volume (which can be
associated with reduced vascular resistance upon baroflex stimulus), retained sodium and water and abnormal hair growth. The most
common adverse reactions of the topical formulation are limited to irritant and allergic contact dermatitis on the scalp. Herein, we report
a non-arteritic anterior ischemic optic neuropathy caused by topical 5% minoxidil treatment that was resolved after discontinuation of
minoxidil. |
|---|---|
| ISSN: | 2249-782X 0973-709X |